Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amylyx, Apollomics, Atsena, Can-Fite, Exelixis, Eyepoint, Okyo, Polaris, Sana, Stoke, Technoderma, Valneva, Viracta.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 280bio, Altimmune, Astrazeneca, CG Oncology, Clarity, Curelab, Everest Medicines, Innovent, Neurona, Pfizer, Qualigen.